FIBROCELL SCIENCE INC's ticker is FCSC and the CUSIP is 315721209. A total of 39 filers reported holding FIBROCELL SCIENCE INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $69,000 | -32.4% | 109,558 | -22.6% | 0.00% | – |
| Q3 2016 | $102,000 | -37.4% | 141,519 | +0.1% | 0.00% | – |
| Q2 2016 | $163,000 | +101.2% | 141,372 | +337.1% | 0.00% | – |
| Q1 2016 | $81,000 | -12.9% | 32,343 | +58.7% | 0.00% | – |
| Q4 2015 | $93,000 | -31.1% | 20,384 | -41.9% | 0.00% | – |
| Q3 2015 | $135,000 | -49.8% | 35,060 | -31.4% | 0.00% | – |
| Q2 2015 | $269,000 | -35.3% | 51,093 | -44.6% | 0.00% | – |
| Q1 2015 | $416,000 | +112.2% | 92,243 | +21.9% | 0.00% | – |
| Q4 2014 | $196,000 | -10.1% | 75,683 | +0.9% | 0.00% | – |
| Q3 2014 | $218,000 | -12.1% | 75,004 | +20.8% | 0.00% | – |
| Q2 2014 | $248,000 | +13.8% | 62,068 | +48.6% | 0.00% | – |
| Q1 2014 | $218,000 | +28.2% | 41,774 | -0.4% | 0.00% | – |
| Q4 2013 | $170,000 | -53.7% | 41,955 | -49.9% | 0.00% | – |
| Q3 2013 | $367,000 | -44.7% | 83,815 | -22.8% | 0.00% | – |
| Q2 2013 | $664,000 | – | 108,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 16,620,414 | $63,989,000 | 2.55% |
| Healthcare Value Capital, LLC | 147,769 | $569,000 | 0.81% |
| Trellus Management Company, LLC | 114,936 | $443,000 | 0.65% |
| AKANTHOS CAPITAL MANAGEMENT LLC | 50,000 | $192,000 | 0.29% |
| MSD Partners, L.P. | 1,997,644 | $7,691,000 | 0.25% |
| QVT Financial LP | 1,870,556 | $7,202,000 | 0.25% |
| Context Capital Management, LLC | 31,010 | $119,000 | 0.22% |
| Geduld E E | 20,100 | $77,000 | 0.07% |
| EMERALD ADVISERS, LLC | 324,425 | $1,249,000 | 0.06% |
| STALEY CAPITAL ADVISERS INC | 110,000 | $423,000 | 0.05% |